Loading

Ligand binding assays: a plethora of technologies to address your projects’ requirements
  • October 27, 2023
  • News

Ligand binding assays: a plethora of technologies to address your projects’ requirements

Ligand binding assays (LBAs) have been our core activity for over 10 years. LBAs are commonly used to measure interactions between two proteins, a ligand and its receptor, a monoclonal antibody (mAb) and its target,…

Read More
Soluble Biomarkers from a global perspective
  • September 26, 2023
  • News

Soluble Biomarkers from a global perspective

Soluble biomarkers: what are they and why are they important in drug development? A biomarker is a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or biological responses to…

Read More
KCAS is Expanding Cutting-Edge Flow Services into Europe
  • August 22, 2023
  • News

KCAS is Expanding Cutting-Edge Flow Services into Europe

KCAS is Expanding Cutting-Edge Flow Services into Europe – What Does This Mean for You and Your International Projects? In an exciting development, KCAS is expanding its flow services in Europe. With the history of…

Read More
Embarking on the Journey of Biologics
  • June 15, 2023
  • News

Embarking on the Journey of Biologics

The Active Approach to Navigating & Solving Bioanalytical Challenges   Biologics are drugs derived from complex molecules like antibodies. Over the last two decades they have re-emerged as game-changers in the treatment of diseases like…

Read More
Computerized Systems Validation Specialist

Computerized Systems Validation Specialist

Performing critical work that impacts our industry and our world’s health while problem solving and innovating in the field – that’s what Scientists at Active Biomarkers get to do every day. If that gets you…

Read More
Immune Profiling: More Than Just A Trend

Immune Profiling: More Than Just A Trend

In recent years, immunology has gained prominence in the life science field, propelled by the literal explosion of cell and gene therapies and novel immunotherapies that train immune cells either to attack various cancers or…

Read More